High-dose medroxyprogesterone acetate in advanced ovarian cancer
Open Access
- 1 August 1991
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 1 (5) , 239-241
- https://doi.org/10.1111/j.1525-1438.1991.tb00047.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Cytoplasmic steroid receptors in ovarian tumoursBJOG: An International Journal of Obstetrics and Gynaecology, 1982
- Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncologyCancer Chemotherapy and Pharmacology, 1982
- High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapyGynecologic Oncology, 1981
- Management of Advanced Ovarian CarcinomaMedical Clinics of North America, 1966